Alvotech and Advanz link-up for Xolair drive
Alvotech will be responsible for supply and Advanz will oversee commercialisation of biosimilar
Read More
Tag: Advanz
Advanz finalises acquisition of Intercept operations across Europe and Canada
The deal will give Advanz an increased presence in the treatment of rare diseases
Read More
Advanz, Morningside, Alliance accused of illegal market sharing
The CMA alleges that Alliance Healthcare bought equal volumes of nitrofurantoin from the companies to discourage competing.
Read More
- Storm Therapeutics and AlidaBio launch collaboration to advance RNA‑targeting cancer therapies
- Excellence adventure
- MHRA approves Nucala for eosinophilic COPD in adults on triple therapy
- Bial launches new sublingual Parkinson’s treatment in UK
- Acesion Pharma launches phase 2 trial of AP31969 in atrial fibrillation
